AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

NEW DATA SHOWS DIOVAN COST-EFFECTIVE IN TREATING HEART PATIENTS.

AsiaPulse News

| September 03, 2002 | COPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(Full text of statement. Contact details below.)

BASEL, Sept 2 PRNewswire-AsiaNet - A new study presented at the European Society of Cardiology (ESC) Congress 2002 shows that Diovan(R) (valsartan), the angiotensin II receptor blocker (ARB), is a highly cost-effective treatment for heart failure patients not taking angiotensin-converting-enzyme (ACE) inhibitors, currently the most widely-prescribed drugs for this disease. Based on new data from the landmark Valsartan Heart Failure Trial (Val-HeFT), the study shows that on average, direct treatment costs were USD $929 lower in heart failure patients who took Diovan along with other heart failure treatments prescribed by their physicians, but not ACE inhibitors. The study was presented by Eric Velazquez, MD, Professor of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.

Val-HeFT previously established that Diovan significantly improves mortality by 33 per cent and reduces hospitalisations for heart failure by 57 per cent in…

Related articles from newspapers, magazines, journals, and more
NOVARTIS RECEIVES FDA APPROVABLE LETTER FOR DIOVAN (VALSARTAN) FOR THE...
Press release article from: PR Newswire October 25, 2001 700+ words
...pleased with FDA's assessment of Diovan in the treatment of heart failure and we will meet with the Agency...indicated in the US for treatment of heart failure. Diovan is also undergoing review for heart failure in several international markets...
Novartis Receives FDA Approvable Letter for Diovan(R) (Valsartan) For the...
Press release article from: PR Newswire October 25, 2001 700+ words
...Administration (FDA) for Diovan(R) (valsartan) for the treatment of heart failure in patients not on an...the US for treatment of heart failure. Diovan is also undergoing review for heart failure in several international...
FDA APPROVES BLOOD PRESSURE TREATMENT DIOVAN FOR HEART FAILURE.
News wire article from: AsiaPulse News August 15, 2002 700+ words
...inhibitors, a common type of heart failure therapy. Diovan, an angiotensin II receptor...results of Val-HeFT show Diovan improves heart failure morbidity and slows the...already support the use of Diovan in heart failure patients who cannot tolerate...
Landmark Trial Demonstrates That Diovan(R) (Valsartan) Significantly Reduces...
Press release article from: PR Newswire November 15, 2000 700+ words
...Novartis Plans to File Diovan for Treatment of Heart Failure in Early 2001 BASEL...study showed that Diovan significantly improved heart failure patients' quality...they progress to heart failure.(4) Diovan, Novartis' flagship...
NOVARTIS FILES FOR GLOBAL INDICATION FOR DIOVAN IN THE TREATMENT OF HEART...
Press release article from: PR Newswire April 30, 2001 700+ words
...The decision to file Diovan for heart failure was based on the positive...major finding was that Diovan significantly reduced heart failure hospitalisations by...before they progress to heart failure.4 Diovan is a highly selective...
FDA Advisory Committee Issues Split Decision on Recommendation To Approve...
Press release article from: PR Newswire October 11, 2001 700+ words
...application (sNDA) for Diovan for heart failure was filed with the...because we believe that Diovan has shown clear benefit in heart failure," said Paulo Costa...demonstrated that heart failure patients taking Diovan with prescribed therapy...
PRESS RELEASE: Novartis files SNDA for Diovan for treatment of heart failure.
News wire article from: Chemical Business Newsbase May 8, 2001 700+ words
...application (SNDA) for Diovan (valsartan) seeking...approval for treatment of heart failure. Diovan is currently indicated...as of 30 Apr 2001. Diovan is the first angiotensin...seek an indication for heart failure in the US. The FDA...
Diovan(R) (Valsartan) Reduces Atrial Fibrillation by 35 Percent in Heart...
Press release article from: PR Newswire September 2, 2003 700+ words
...with their usual heart failure therapy, meaning that Diovan reduced or prevented...HeFT showed that Diovan significantly reduces heart failure morbidity vs...In patients with heart failure, concomitant use of Diovan, an ACE inhibitor...
ADVISORY/Novartis Files SNDA for Diovan for Treatment of Heart Failure.
Press release article from: Business Wire April 30, 2001 700+ words
...application (SNDA) for Diovan(R) (valsartan...approval for treatment of heart failure. Diovan is currently indicated...the U.S. today. Diovan is the first angiotensin...seek an indication for heart failure in the U.S. Filings...
Novartis gets broader FDA indication, for heart failure, on Diovan.
Newspaper article from: Pharma Marketletter August 15, 2005 700+ words
...expanded the drug's heart-failure labeling, so that Diovan can now be prescribed...broader range of heart failure patients and is...and people with heart failure. This US approval...were granted for Diovan in 14 European Union...
For more facts and information, see all results

Source: HighBeam Research, NEW DATA SHOWS DIOVAN COST-EFFECTIVE IN TREATING HEART PATIENTS.

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily